Difficulty: Medium
Average Score: 74%
Practice
A 29-year-old man is found to have primary pulmonary hypertension while undergoing a workup for shortness of breath and fatigue. A defect in his BMPR2 gene is discovered. This gene product normally inhibits smooth muscle proliferation. Which of the following drugs would best help this patient?
Correct answer
A
Rationale
Bosentan, an endothelin receptor antagonist, reduces pulmonary vascular resistance and smooth muscle proliferation in pulmonary hypertension linked to BMPR2 defects.